<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="2" ids="5615">Halothane</z:chebi> is a strong inhibitor of <z:chebi fb="120" ids="26216">potassium</z:chebi> evoked spreading <z:hpo ids='HP_0000716'>depression</z:hpo> (SD) in cats </plain></SENT>
<SENT sid="1" pm="."><plain>In the current study, we investigate <z:chebi fb="2" ids="5615">halothane</z:chebi> effects on induction of perifocal SD-like depolarizations, CBF, and <z:mpath ids='MPATH_124'>infarct</z:mpath> evolution in focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="8" ids="33050">Calomel</z:chebi> and <z:chebi fb="240" ids="33364,33400">platinum</z:chebi> electrodes measured cortical direct current potential and CBF in ectosylvian, suprasylvian, and marginal gyri </plain></SENT>
<SENT sid="3" pm="."><plain>Left middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) induced permanent focal <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> for 16 hours in artificially ventilated cats (30% oxygen, 70% nitrous <z:chebi fb="177" ids="25741,29356">oxide</z:chebi>) under <z:chebi fb="2" ids="5615">halothane</z:chebi> (0.75%, n = 8) or alpha-chloralose anesthesia (60 mg/kg intravenously, n = 7) </plain></SENT>
<SENT sid="4" pm="."><plain>Under alpha-chloralose, MCAO induced severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> in ectosylvian and suprasylvian gyri(mean CBF &lt; 10 mL/100 g/min), and direct current potentials turned immediately into terminal depolarization </plain></SENT>
<SENT sid="5" pm="."><plain>In marginal gyri, CBF reduction was mild (more than 20 mL/100 g/min), and in six of seven animals, frequent SD-like depolarizations turned into terminal depolarization at a later stage of the experiments </plain></SENT>
<SENT sid="6" pm="."><plain>Under <z:chebi fb="2" ids="5615">halothane</z:chebi>, MCAO induced severe <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (less than 10 mL/100 g/min) and immediate terminal depolarization only in ectosylvian gyrus </plain></SENT>
<SENT sid="7" pm="."><plain>In suprasylvian gyrus, residual CBF remained significantly higher (more than 10 mL/100 g/min) than under alpha-chloralose, whereas in marginal gyri, CBF did not differ between groups </plain></SENT>
<SENT sid="8" pm="."><plain>Compared with chloralose, the number of transient depolarizations was significantly reduced in marginal gyrus, and in suprasylvian gyrus transient but significantly longer depolarizations than in marginal gyrus were recorded </plain></SENT>
<SENT sid="9" pm="."><plain>Except for one animal, transient depolarizations did not turn into terminal depolarization under <z:chebi fb="2" ids="5615">halothane</z:chebi>, and <z:mpath ids='MPATH_124'>infarct</z:mpath> volume reduction was particularly seen in suprasylvian gyrus </plain></SENT>
<SENT sid="10" pm="."><plain>We conclude that <z:chebi fb="2" ids="5615">halothane</z:chebi>, the most commonly used <z:chebi fb="164" ids="38867">anesthetic</z:chebi> in studies of experimental <z:e sem="disease" ids="C0007786" disease_type="Disease or Syndrome" abbrv="">brain ischemia</z:e>, has protective properties, which may depend on both cerebrovascular and electrophysiologic influences </plain></SENT>
</text></document>